Back to search results
NCT06703450

Guerbet Liver Fibrosis

Enrolling by Invitation
Not specifiedAges 18–89Observational
Icahn School of Medicine at Mount Sinai
~50 participants
Updated 2026-04-21 on ClinicalTrials.gov

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Liver Stiffness by MR Elastography
Measured over during procedure (MRI)

Conditions

Metabolic Dysfunction-associated Steatotic Liver Disease

Explore related trials

Nonalcoholic Fatty Liver DiseaseNonalcoholic Steatohepatitis

NCT06703450

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Mount Sinai

    New York, New Yorkno site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Sara Lewis, MD · PRINCIPAL_INVESTIGATOR · Icahn School of Medicine at Mount Sinai

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Patients with suspected MASLD (F0-F4) with clinically indicated percutaneous or transjugular liver biopsy within 6 months of MRI (before or after MRI).
Both genders.
Age \> 18 years.
Any racial/ethnic background.

Exclusion

Previous history or current diagnosis of HCC or decompensation.
Contraindications for MRI, including
Medically unstable
Intracranial clips
Metal implants
Suspected or confirmed metal in eyes
Cardiac pacemaker, implanted defibrillator, other implanted electronic device
Pregnancy: Pregnancy tests will be offered to women of childbearing age at no cost
Severe claustrophobia

What this trial measures

  • Liver Stiffness by MR Elastographyduring procedure (MRI)

    Liver stiffness that is quantitively measured by MR Elastography and correlated with grade of tissue fibrosis from histopathology. Min and Max Scale: 0-20 kilopascals (continuous variable). Higher score indicates poorer health outcomes.